In re Cardinal Health, Inc.

226 F.R.D. 298, 60 Fed. R. Serv. 3d 868, 2005 U.S. Dist. LEXIS 1431, 2005 WL 238073
CourtDistrict Court, S.D. Ohio
DecidedJanuary 26, 2005
DocketNo. C2-04-575
StatusPublished
Cited by29 cases

This text of 226 F.R.D. 298 (In re Cardinal Health, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re Cardinal Health, Inc., 226 F.R.D. 298, 60 Fed. R. Serv. 3d 868, 2005 U.S. Dist. LEXIS 1431, 2005 WL 238073 (S.D. Ohio 2005).

Opinion

ORDER APPOINTING LEAD PLAINTIFF

MARBLEY, District Judge.

I. INTRODUCTION

This matter comes before the Court on five Plaintiffs’ motions to be Lead Plaintiff and [300]*300Appoint Lead Counsel for this Consolidated Securities Action against Cardinal Health, Inc. (“Cardinal Health” or “Cardinal” or “the Company”) and various related Defendants.1 The Court GRANTS the Pension Fund Group’s Motion for Appointment as Lead Plaintiff and Its Selection of Lead Counsel to Consolidate Related Actions [Docket No. 36]; DENIES the State of New Jersey’s Motion for Appointment as Proposed Lead Plaintiff and For Approval of Selection of Counsel [Docket No. 23]; DENIES First New York LLC’s Motion for Appointment as Lead Plaintiff and Approval of Its Selection of Co-Lead and Liaison Counsel [Docket No. 31]; DENIES Wood Asset Management’s Motion to Appoint Counsel Gold Bennett Cera & Sidener LLP, as Lead Counsel and Wood Asset Management, Inc. as Lead Plaintiff [Docket No. 17]; DENIES the Engel Family Trust’s Motion for an Order to Appoint The Engel Family Trust Lead Plaintiff and Approval of Lead Counsel [Docket No. 30].

II. SUMMARY OF PENDING ACTIONS AND UNDERLYING FACTS

Taking the facts as stated by the Plaintiffs, these securities fraud class actions have been brought against Cardinal Health and related Defendants on behalf of all persons who purchased the publicly traded securities of Cardinal Health, Inc. from October 24, 2000 to July 26, 2004 (“the Class Period”).2 Cardinal Health is a holding company encompassing a number of operating subsidiaries that do business as Cardinal Health. It is a provider of products and services supporting the healthcare industry. During the Class Period, Defendants allegedly caused Cardinal Health’s shares to trade at artificially inflated levels through the issuance of false and misleading financial statements, by using questionable inventory practices, and by prematurely recording approximately $22 million in the December 2000 and September 2001 quarters for a law suit settlement, which did not actually settle until mid-2002. These various manipulations were aimed to meet Wall Street analysts’ earnings targets for December 2000 and September 2001. Taking advantage of the inflation of Cardinal’s stock caused by their false statements, Cardinal insiders allegedly sold over 2.2 million shares of their own Cardinal stock at artificially inflated prices, reaping gross proceeds in excess of $152 million.

On October 7, 2003, however, Cardinal received a request from the Securities and Exchange Commission (“SEC”), in connection with an informal inquiry, for historical financial and related information, including Cardinal’s accounting records for fiscal 2001 through fiscal 2003, as well as notes, memoranda, presentations, e-mail and other correspondence, budgets, forecasts and estimates. Since October 2003, Cardinal has been collecting and providing to the SEC documents responsive to the October request.

In April 2004, the Company’s audit committee began an internal review and retained independent counsel to investigate certain accounting matters. On May 6, 2004, the Company was notified that the pending SEC inquiry had been converted into a formal investigation. This information was disclosed to the public on May 14, 2004. On June 30, 2004, Cardinal issued a press release and later conducted a conference call for analysts that disclosed a significant earnings shortfall, due in part to “a faster elimination of inventory investment opportunities,” and disclosed that Cardinal had received a subpoena from the SEC that “included a request for the production of documents relating to revenue classification, [301]*301and the methods used for such classification, in the company’s pharmaceutical distribution business as either operating revenue or revenues from bulk deliveries to customer warehouses.” That day, the company also disclosed that the United States Attorney’s Office for the Southern District of New York had commenced an investigation on the same subject. In response the stock fell by $17.19 per share, more than 24%, in the next day’s trading.

On July 26, 2004, after the market closed, the Company announced that its Chief Financial Officer, Richard Miller, had resigned and that the company would be delaying the release of its Fourth Quarter and Fiscal Year 2004 annual results until August or early September. When Cardinal Health stock resumed trading on July 27, 2004, the company’s stock fell by $6.47 to close at $44.00, a single day decline of 13%. Since Miller’s resignation, the stock has remained at approximately $45.00 per share.

The first motion in this case was filed in this Court on July 2, 2004 pursuant to the Private Securities Litigation Reform Act (“PSRLA”). 15 U.S.C. § 78u-4. Gerald Burger et al. v. Cardinal Health, Case No. 04-575, 2004 WL 2301110 (complaint filed July 2, 2004). Upon filing the Complaint, counsel also published the required notice to members of the purported class, which advised class members of the existence of the lawsuit and described the claims asserted. 15 U.S.C. § 78u-4(a)(3)(A)(i). It also advised class members of their right to file a motion for Lead Plaintiff no later than August 31, 2004. 15 U.S.C. § 78u-4(a)(3)(A)(i)(II) (“[N]ot later than 60 days after the date on which the notice is published, any member of the purported class may move the court to serve as lead plaintiff of the purported class.”).

The following Lead Plaintiff candidates have emerged:3

1. State of New Jersey, Department of Treasury, Division of Investment (“New Jersey”);

2. First New York Securities, LLC (“First New York”);

3. The Pension Fund Group (“Pension Fund Group” or “PFG”);

4. Wood Asset Management, Inc. (“Wood Asset Management”); and

5. Engel Family Trust4

On December 16, 2004, the Court entered an order consolidating all securities actions. On January 11, 2005, the Court held a hearing during which each of the proposed Lead Plaintiffs had an opportunity to present its arguments. The Court has reviewed the parties’ motions, responses, and replies thereto, and has fully considered the arguments heard at oral argument.

III. ANALYSIS

A. Legal Framework of the PSLRA

The PSLRA requires that the Court appoint a lead plaintiff during the initial stages of litigation. If an action has been consolidated, the court shall appoint a lead plaintiff “as soon as practicable” after the consolidation. 15 U.S.C. § 78u-4(a)(3)(B)(ii). The PSLRA further dictates that the chosen lead plaintiff be able to represent adequately the interests of the class members.

[T]he court ...

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
226 F.R.D. 298, 60 Fed. R. Serv. 3d 868, 2005 U.S. Dist. LEXIS 1431, 2005 WL 238073, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-cardinal-health-inc-ohsd-2005.